Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial

Koscielniak, Ewa; Ljungman, Gustaf; Kazanowska, Bernarda; Niggli, Felix; Sparber-Sauer, Monika; Handgretinger, Rupert; Zimmermann, Martin; Boos, Joachim; Blank, Bernd; Hallmen, Erika; von Luettichau, Irene Teichert; Schmid, Irene; Froehlich, Birgit; Mueller, Hermann L.; Behnisch, Wolfgang; Ladenstein, Ruth; Scheer, Monika; Vokuhl, Christian; von Kalle, Thekla; Blattmann, Claudia; Bielack, Stefan; Klingebiel, Thomas

Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial

Autor(en):

Koscielniak, Ewa; Ljungman, Gustaf; Kazanowska, Bernarda; Niggli, Felix; Sparber-Sauer, Monika; Handgretinger, Rupert; Zimmermann, Martin; Boos, Joachim; Blank, Bernd; Hallmen, Erika; von Luettichau, Irene Teichert; Schmid, Irene; Froehlich, Birgit; Mueller, Hermann L.; Behnisch, Wolfgang; Ladenstein, Ruth; Scheer, Monika; Vokuhl, Christian; von Kalle, Thekla; Blattmann, Claudia; Bielack, Stefan; Klingebiel, Thomas

Tübinger Autor(en):

Koscielniak, Ewa
Sparber-Sauer, Monika
Handgretinger, Rupert
Blattmann, Claudia

Erschienen in:

Eclinicalmedicine (2024), Bd. 78, Article 102957

Verlagsangabe:

Amsterdam : Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.eclinm.2024.102957

ISSN:

2589-5370